Clinical trial
Optimizing Pazopanib Exposure in RCC Patients through Therapeutic Drug Monitoring Followed by Intrapatient Dose Escalation
Determine if in patients with a Pazopanib plasma trough level of ? 20 ?g/mL a plasma trough level of > 20 ?g/mL can be achieved by dose escalation.
| Category | Value |
|---|---|
| Study start date | 2013-03-05 |